World's Best Scientists 2026 revealed!
Michel J. Tremblay

Michel J. Tremblay

D-Index & Metrics

Immunology

D-Index
71
Citations
16161
World Ranking
2340
National Ranking
53

Michel J. Tremblay publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michel J. Tremblay sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 302 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michel J. Tremblay D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michel J. Tremblay sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michel J. Tremblay is affiliated with Université Laval in Canada and conducts research primarily within the fields of Immunology and Microbiology as well as Medicine. Their work spans several subfields including Virology, Immunology, Infectious Diseases, Emergency Medicine, and Microbiology.

The scientist's research topics prominently focus on HIV Research and Treatment, HIV-related health complications and treatments, Immune Cell Function and Interaction, Immune cells in cancer, Reproductive tract infections research, HIV/AIDS Research and Interventions, and interferon and immune responses.

Recent publications by Michel J. Tremblay include the following papers:

  • HIV-1 infection and latency-reversing agents bryostatin-1 and JQ1 disrupt amyloid beta homeostasis in human astrocytes, 2020, Glia
  • Comparing Current and Next-Generation Humanized Mouse Models for Advancing HIV and HIV/Mtb Co-Infection Studies, 2022, Viruses
  • Immunocompetent Human 3D Organ-Specific Hormone-Responding Vaginal Mucosa Model of HIV-1 Infection, 2021, Tissue Engineering Part C Methods
  • The delicate balance between neurotoxicity and neuroprotection in the context of HIV-1 infection, 2020, Glia
  • Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice, 2021, Scientific Reports

Michel J. Tremblay has frequently published in the following venues:

  • Scientific Reports
  • Glia
  • Journal of Virology
  • Viruses
  • Tissue Engineering Part C Methods

Their collaborative network includes frequent co-authors such as:

  • Corinne Barat
  • Michel Ouellet
  • Mathieu Lebœuf
  • Marie-Thérèse Gagnon
  • François Vanasse

Best Publications

  • Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation.

    Aisha Nazli;Olivia Chan;Wendy N. Dobson-Belaire;Michel Ouellet

  • Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity.

    J F Fortin;R Cantin;G Lamontagne;M Tremblay

  • Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

    Moutih Rafei;Jeremy Hsieh;Simon Fortier;MengYang Li

  • Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element

    Dominique L. Ouellet;Isabelle Plante;Patricia Landry;Corinne Barat

  • The acquisition of host-encoded proteins by nascent HIV-1

    Michel J Tremblay;Jean-François Fortin;Réjean Cantin

  • Plunder and stowaways : Incorporation of cellular proteins by enveloped viruses

    Réjean Cantin;Sylvie Méthot;Michel J. Tremblay

  • The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways.

    Alexandra A. Lambert;Caroline Gilbert;Manon Richard;André D. Beaulieu

  • Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group.

    Rooke R;Tremblay M;Soudeyns H;DeStephano L

  • Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo

    Salim Bounou;Jacques E. Leclerc;Michel J. Tremblay

  • Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models.

    Gaétan Roy;Carole Dumas;Denis Sereno;Ying Wu

  • Galectin-1 Acts as a Soluble Host Factor That Promotes HIV-1 Infectivity through Stabilization of Virus Attachment to Host Cells

    Michel Ouellet;Simon Mercier;Isabelle Pelletier;Salim Bounou

  • Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species

    Frédéric Raymond;Sébastien Boisvert;Gaétan Roy;Jean-François Ritt

  • The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.

    R Cantin;J F Fortin;G Lamontagne;M Tremblay

  • Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.

    Marie Breton;Michel J Tremblay;Marc Ouellette;Barbara Papadopoulou

  • HIV-1 gp120 Induces TLR2- and TLR4-Mediated Innate Immune Activation in Human Female Genital Epithelium

    Aisha Nazli;Jessica K. Kafka;Victor H. Ferreira;Varun Anipindi

  • Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation.

    Bélanger C;Gravel A;Tomoiu A;Janelle Me

  • T Cells Expressing Activated LFA-1 Are More Susceptible to Infection with Human Immunodeficiency Virus Type 1 Particles Bearing Host-Encoded ICAM-1

    Jean-François Fortin;Réjean Cantin;Michel J. Tremblay

  • Overexpression of seleno-glutathione peroxidase by gene transfer enhances the resistance of T47D human breast cells to clastogenic oxidants.

    M E Mirault;A Tremblay;N Beaudoin;M Tremblay

  • Hyper-responsiveness to Stimulation of Human Immunodeficiency Virus-infected CD4+ T Cells Requires Nef and Tat Virus Gene Products and Results from Higher NFAT, NF-κB, and AP-1 Induction

    Jean-François Fortin;Corinne Barat;Yannick Beauséjour;Benoit Barbeau

  • Activation of HIV-1 Long Terminal Repeat Transcription and Virus Replication via NF-κB-dependent and -independent Pathways by Potent Phosphotyrosine Phosphatase Inhibitors, the Peroxovanadium Compounds

    Benoit Barbeau;Richard Bernier;Nancy Dumais;Guylaine Briand

Frequent Co-Authors

Michel G. Bergeron
Michel G. Bergeron Université Laval
Mark A. Wainberg
Mark A. Wainberg McGill University
Martin Olivier
Martin Olivier McGill University
Marc Ouellette
Marc Ouellette Université Laval
Barbara Papadopoulou
Barbara Papadopoulou Université Laval
Tony Mazzulli
Tony Mazzulli University Health Network
Ali A. Ashkar
Ali A. Ashkar McMaster University
Louis Flamand
Louis Flamand Université Laval
Rémi Fromentin
Rémi Fromentin University of Montreal
Jacques Corbeil
Jacques Corbeil Université Laval

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students find that transitioning into nursing complements their knowledge of immune system functions, especially when considering patient care roles.

If you’re new to nursing, there are excellent options like online BSN programs for non nurses that provide a flexible and accessible way to enter the field. These programs cater to individuals without prior nursing experience, making them ideal for Immunology graduates seeking practical healthcare credentials.

For those aiming for quicker entry, accelerated nursing programs near me offer a fast-tracked path to becoming a registered nurse by building on existing academic skills.

Additionally, gaining licensure as a Practical Nurse can be simpler than expected. Many candidates take advantage of lpn programs with easiest admission requirements to quickly enter the nursing workforce and develop clinical skills relevant to immunological studies.

For advanced practice, becoming a Family Nurse Practitioner is a strong option. Exploring the easiest fnp program can help identify accessible routes to certification, allowing professionals to combine immunology expertise with primary care.

Best Scientists Citing Michel J. Tremblay

Trending Scientists

Recently Published Articles